ArticleJournal of hand surgery global online2026
Total Elbow Arthroplasty Complication, Reoperation, and Revision Rates: A Comparison Between Arthroplasty for Arthritis Versus Fracture.
Article in Journal of hand surgery global online, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Total elbow arthroplasty (TEA) can be used to treat both distal humerus fractures and arthritis of the elbow joint. This study aimed to compare complication, reoperation, and revision rates following TEA between these two indications. Methods: A retrospective review of TEA was performed within a single large orthopedic practice. All patients who had undergone a TEA between 2016 and 2020, yielding 96 TEA cases for analysis, were queried. TEA cases were categorized by indication into arthritis diagnoses (AX) and distal humerus fractures (FX). Demographic and clinical data, complications, reoperations, and revisions were recorded over a 4-year follow-up period. Kaplan-Meier implant survival and multivariable analyses were performed. Results: A total of 96 TEAs (54 AX and 42 FX) with a mean age of 70.3 ± 12.4 years were included, among which 78% (75/96) were women. Patients in the AX group (64.8 ± 10.9 years) were younger than those in the FX group (77.5 ± 10.5 years). The overall TEA complication rate was 42%, and the reoperation rate was 23%. The AX group had higher rates of complications (44% vs 38%) and reoperations (30% vs 14%) than the FX group. Overall, men had higher rates of both complications (76% vs 33%) and reoperations (43% vs 19%) than women. Survival analysis for any reoperation at 4 years showed TEA for FX having higher survival (86%) than TEA for AX (70%). On multivariable analysis, only being male was associated with more complications, but the model was unstable because of low sample size. Conclusions: Almost one-half of TEA patients experienced complications and approximately one in four required reoperation within 4 years postop. Total elbow arthroplasty remains associated with substantial complication and reoperation rates. Surgical indication and gender may influence postoperative TEA outcomes. Type of study/level of evidence: Prognosis IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.